Benzinga | Sep 29, 2021 08:28AM EDT

Cassava Sciences Sponsored Study Titled 'Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease (RETHINK-ALZ)' Posted To ClinicalTrials.Gov; Study Is Recruiting

https://www.clinicaltrials.gov/ct2/show/NCT04994483?term=Simufilam&draw=2&rank=2